Efanesoctocog alfa for treating and preventing bleeding episodes in haemophilia A in people 2 years and over

  • Technology appraisal guidance
  • TA1051
  • Published: 

Evidence

Documents containing the evidence that was used to develop the recommendations.

Supporting evidence